EP03.02 IMAGING-BASED PREDICTION OF 5-ALA FLUORESCENCE IN GLIOMAS USING PREOPERATIVE 7T MRSI COMPARED TO T1W MRI AND PET
Abstract BACKGROUND Maximizing the extent of safe tumor resection is a critical factor influencing survival outcomes in glioma patients. The use of 5-aminolevulinic acid (5-ALA) fluorescence has proven effective in enhancing resection, particularly in high-grade gliomas (HGG), where it is routinely applied. However, its utility in low-grade gliomas (LGG), especially those without significant contrast enhancement (CE), remains unclear. Clinically, T1-weighted contrast-enhanced MRI and PET imaging have shown strong associations with intraoperative 5-ALA fluorescence. This study investigated whether 7T Magnetic Resonance Spectroscopic Imaging (MRSI) could serve as a reliable preoperative tool to predict 5-ALA fluorescence, comparing its performance to that of established imaging modalities. MATERIAL AND METHODS We retrospectively evaluated 42 patients with histologically confirmed diffusely infiltrating adult-type gliomas who underwent preoperative 7T MRSI and 5-ALA fluorescence-guided surgery. Group comparisons were conducted using the Mann-Whitney U test and Chi-square test. Predictive performance was assessed using receiver operating characteristic (ROC) curve analysis and multivariate logistic models. RESULTS Significantly higher median metabolite ratios were observed in 5-ALA-positive tumors compared to 5-ALA-negative ones: Gln/tCr (p<0.001), Glx/tCr (p<0.001), Gly/tCr (p<0.001), and GSH/tCr (p<0.001) were observed in 5-ALA-positive tumors compared to 5-ALA-negative ones. The ratio of mIns/tNAA was significantly lower in the 5-ALA positive compared to the 5-ALA negative group. ROC analysis revealed strong predictive accuracy for 5-ALA fluorescence using: mIns/tNAA (81%) Gln/tCr (88%), Glx/tCr (87%), Gly/tCr (86%), and GSH/tCr (83%), with the combined accuracy of 94%. In comparison, the presence of CE on MRI predicted fluorescence was predicted in 68% of cases, while PET imaging predicted it in 86%. CONCLUSION Preoperative quantification of mIns/tNAA, Gln/tCr, Glx/tCr, Gly/tCr, and GSH/tCr ratios via 7T MRSI may effectively predict intraoperative 5-ALA fluorescence. These findings support the use of ultra-high-field MRSI as a valuable tool for surgical planning and patient selection for 5-ALA administration, with the potential to improve resection outcomes in glioma treatment.
Authors
- Cornelius Cadrien (ORCID: https://orcid.org/0000-0002-0341-2209)
- Karl Roessler (ORCID: https://orcid.org/0000-0002-9249-8082)
- Günther Grabner (ORCID: https://orcid.org/0000-0001-8330-8446)
- Wolfgang Bogner (ORCID: https://orcid.org/0000-0002-0130-3463)
- Lukas Hingerl (ORCID: https://orcid.org/0000-0003-1808-8349)
- Julia Furtner (ORCID: https://orcid.org/0000-0001-8258-3681)
- Barbara Kiesel (ORCID: https://orcid.org/0000-0003-0939-9831)
- Thomas Roetzer-Pejrimovsky (ORCID: https://orcid.org/0000-0001-8875-7304)
- Lucas J. Koerner (ORCID: https://orcid.org/0000-0002-7236-7202)
- Gilbert Hangel (ORCID: https://orcid.org/0000-0002-3986-3159)
- Bernhard Strasser (ORCID: https://orcid.org/0000-0001-9542-3855)
- Georg Widhalm (ORCID: https://orcid.org/0000-0001-6014-0273)
- Philipp Lazen (ORCID: https://orcid.org/0000-0002-9952-3084)
- Judith Leitner (ORCID: https://orcid.org/0000-0002-7156-1759)
- Sara Huskić
- Anita Kloss-Brandstaetter
Institutions
- FH Kärnten (AT)
- University of Klagenfurt (AT)
- Medical University of Vienna (AT)
Publication Details
- Journal
- Neuro-Oncology
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1093/neuonc/noaf193.591
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00